ES474900A1 - Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados - Google Patents

Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados

Info

Publication number
ES474900A1
ES474900A1 ES474900A ES474900A ES474900A1 ES 474900 A1 ES474900 A1 ES 474900A1 ES 474900 A ES474900 A ES 474900A ES 474900 A ES474900 A ES 474900A ES 474900 A1 ES474900 A1 ES 474900A1
Authority
ES
Spain
Prior art keywords
alkyl
ring system
phenyl
optionally
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES474900A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Leo Pharma AS
Original Assignee
Leo Pharmaceutical Products Ltd AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharmaceutical Products Ltd AS filed Critical Leo Pharmaceutical Products Ltd AS
Publication of ES474900A1 publication Critical patent/ES474900A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms
    • C07D215/42Nitrogen atoms attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pain & Pain Management (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)

Abstract

Método para producir nuevos N''`-4-quinolilguanidinas N,N''-disustituidas para la terapia de la artritis reumatoide, osteo-artritis y estados relacionados, que responden a la fórmula general I: ** (Ver fórmula I) ** en la que R1 representa el hidrógeno, alquilo en C1-C6, alcoxi en C1-C6, hidroxi, halógeno, trifluorometilo, o fenilo; R2 representa el hidrógeno, alquilo en C1-C6, alcoxi en C1-C6, halógeno, trifluorometilo, o hidroxi; R3 representa alquilo en C1- C18, o cicloalquilo en C3-C8 que puede ser además mono- o di-sustituido con metilo o etilo, o fenilo o fenil-alquilo en C1-C3 que puede además ser sustituido con metilo, metoxi, halo o trifluorometilo; y R4 representa un sistema de anillo heterocíclico de 5 ó 6 miembros que contiene al menos un átomo de nitrógeno y conteniendo además opcionalmente átomos de nitrógeno, oxígeno y/o azufre, estando sustituido opcionalmente dicho sistema de anillo con alquilo en C1-C3, carboxi, carbalcoxi, halógeno, trifluorometilo, hidroxi y/o mercapto; oformando parte opcionalmente dicho sistema de anillo de un sistema de anillo fundido más grande; y las sales, complejos o derivados acilados farmacéuticamente aceptables no tóxicos del mismo.
ES474900A 1977-11-07 1978-11-07 Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados Expired ES474900A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4616677 1977-11-07

Publications (1)

Publication Number Publication Date
ES474900A1 true ES474900A1 (es) 1980-04-16

Family

ID=10440127

Family Applications (1)

Application Number Title Priority Date Filing Date
ES474900A Expired ES474900A1 (es) 1977-11-07 1978-11-07 Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados

Country Status (24)

Country Link
US (1) US4293549A (es)
JP (1) JPS5473784A (es)
AT (1) AT366368B (es)
AU (1) AU517670B2 (es)
BE (1) BE871807A (es)
CA (1) CA1120929A (es)
CH (1) CH645354A5 (es)
DE (1) DE2847792A1 (es)
DK (1) DK153950C (es)
ES (1) ES474900A1 (es)
FI (1) FI69463C (es)
FR (1) FR2407930A1 (es)
GR (1) GR65010B (es)
IE (1) IE47458B1 (es)
IT (1) IT1100075B (es)
LU (1) LU80476A1 (es)
NL (1) NL7811035A (es)
NZ (1) NZ188770A (es)
PH (1) PH16296A (es)
PT (1) PT68750A (es)
SE (1) SE446267B (es)
SU (1) SU828967A3 (es)
YU (1) YU41129B (es)
ZA (1) ZA786175B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6306846B1 (en) * 1972-05-31 2001-10-23 John R. J. Sorenson Anti-inflammatory and anti-ulcer compounds and process
IT1205640B (it) * 1983-04-06 1989-03-23 Yason Srl Nuovi composti ad attivita' antiinfiammatoria,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
US4563460A (en) * 1984-01-13 1986-01-07 William H. Rorer, Inc. Quinoline and quinazoline derivatives for treating gastrointestinal motility dysfunctions
HU195487B (en) * 1985-06-04 1988-05-30 Egyt Gyogyszervegyeszeti Gyar Process for producing quinoline derivatives
EP0259085B1 (en) * 1986-08-29 1991-08-21 Pfizer Inc. 2-guanidino-4-arylthiazoles for treatment of peptic ulcers
US6100260A (en) * 1997-04-21 2000-08-08 Sumitomo Pharmaceutical Company, Limited Isoxazole derivatives
EP0928793B1 (en) * 1998-01-02 2002-05-15 F. Hoffmann-La Roche Ag Thiazole derivatives
BR9909666A (pt) * 1998-03-26 2001-09-11 Japan Tobacco Inc Derivados de amida e antagonistas de nociceptina
JP2003513064A (ja) * 1999-11-05 2003-04-08 ユニバーシティ カレッジ ロンドン 可溶性グアニル酸シクラーゼのアクチベーター
WO2004063181A1 (en) * 2003-01-03 2004-07-29 Genzyme Corporation Urea derivatives and their use as anti-inflammatory agents
WO2004064730A2 (en) * 2003-01-14 2004-08-05 Cytokinetics, Inc. Compounds, compositions and methods
GB0404434D0 (en) * 2004-02-27 2004-03-31 Novartis Ag Organic compounds
WO2007022964A2 (de) * 2005-08-24 2007-03-01 Abbott Gmbh & Co. Kg Hetaryl substituierte guanidinverbindungen und ihre verwendung als bindungspartner für 5-ht5-rezeptoren
CN117677386A (zh) * 2021-07-23 2024-03-08 瓦伦塔有限责任公司 具有亲溶酶体和抗病毒活性的化合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB889282A (en) * 1957-05-07 1962-02-14 Air Reduction Preparation of hexafluorodiethyl ether and medicinal compositions containing it
GB889262A (en) * 1959-07-03 1962-02-14 Ciba Ltd Quinoline compounds
US3159676A (en) * 1962-02-07 1964-12-01 Smith Kline French Lab Naphthyl containing guanidines
US3852293A (en) 1972-06-21 1974-12-03 Uniroyal Inc 4-phenyl-2-(3-pyridyl)-thiazole carboxamides
US4000279A (en) * 1974-10-29 1976-12-28 Armour Pharmaceutical Company Pharmaceutical preparations containing 5'-(8'-hydroxyquinolyl)guanidine compounds and methods of using same

Also Published As

Publication number Publication date
NL7811035A (nl) 1979-05-09
FI69463B (fi) 1985-10-31
FI783327A (fi) 1979-05-08
YU257578A (en) 1983-01-21
FR2407930A1 (fr) 1979-06-01
FI69463C (fi) 1986-02-10
PH16296A (en) 1983-09-05
US4293549A (en) 1981-10-06
ATA773278A (de) 1981-08-15
AT366368B (de) 1982-04-13
BE871807A (fr) 1979-05-07
IT1100075B (it) 1985-09-28
DK493378A (da) 1979-05-08
CH645354A5 (de) 1984-09-28
SE446267B (sv) 1986-08-25
AU4137678A (en) 1979-05-17
YU41129B (en) 1986-12-31
ZA786175B (en) 1979-10-31
PT68750A (en) 1978-12-01
CA1120929A (en) 1982-03-30
DK153950B (da) 1988-09-26
FR2407930B1 (es) 1983-03-18
DK153950C (da) 1989-02-20
DE2847792C2 (es) 1988-02-04
SE7811457L (sv) 1979-05-08
NZ188770A (en) 1984-07-31
DE2847792A1 (de) 1979-05-10
GR65010B (en) 1980-06-12
IT7829514A0 (it) 1978-11-07
LU80476A1 (fr) 1979-06-15
IE782084L (en) 1979-05-07
JPS5473784A (en) 1979-06-13
AU517670B2 (en) 1981-08-20
JPS6348873B2 (es) 1988-09-30
IE47458B1 (en) 1984-03-21
SU828967A3 (ru) 1981-05-07

Similar Documents

Publication Publication Date Title
ES474900A1 (es) Metodo para producir nues n''-4-quinolilguanidinas n,n'-di- sustituidas para la terapia de la artritis reumatoide, os- teo-artritis y estados relacionados
SE7705957L (sv) Forfarande for framstellning av nya tetracykliska derivat
GB1527297A (en) Pyrazine carboxamides
ATE63914T1 (de) N6-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel.
UA48937C2 (uk) Імідазолідини, заміщені гетероциклом, спосіб їх одержання і фармацевтична композиція, що їх містить
ES8405009A1 (es) Un procedimiento para la preparacion de imidazodiacepinas.
GB1086192A (en) Phenylcyclopropane derivatives
GB1187259A (en) New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture
SE8102220L (sv) Anvendning av substituerade derivat av 4-fenyl-4-oxo-2-butensyra sasom lekemedel
NO160783C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte beta-karbolinderivater.
ES8400079A1 (es) Procedimiento para la preparacion de derivados de ciclohexe-no
ES446993A1 (es) Un procedimiento para la preparacion de nuevos derivados de benzofenona.
SE7605819L (sv) Nya propargyl-2-fenylaminoimidazolin-(2), dess syraadditionssalter, lekemedel innehallande dessa och forfarande for framstellning derav
ES467069A1 (es) Un procedimiento para la preparacion de nuevos derivados de 1-3-bencenodimetanol
ES480827A1 (es) Procedimiento para la preparacion de acidos fenilaminotiofe-noaceticos.
GB1141936A (en) Improvements in or relating to benzimidazole derivatives
ES475533A1 (es) Un metodo para la preparacion de formas racemicas y optica- mente activas de 2-(4-difenilil)-n-(dimetilamino-alquil)pro-pionamida
GB2009155A (en) Pyridine Derivatives
ES468127A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido (2,1-b) quinazolina
ZA831477B (en) Substituted pyridines,processes for preparing these and pharmaceutical composition thereof
SE7900601L (sv) 1-naftyl-ettiksyraderivat jemte forfarande for deras framstellning
ES419019A1 (es) Procedimiento para la preparacion de compuestos polici- clicos.
ES448989A1 (es) Procedimiento para la obtencion de derivados alquinicos.
GB1254270A (en) Benzoxazepine derivatives
ES462838A1 (es) Procedimiento para la preparacion de compuestos tetracicli- cos biologicamente activos.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19990201